Pancreatic Insufficiency in Adult Celiac Disease: Do Patients Require Long-Term Enzyme Supplementation?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Celiac disease is associated with exocrine pancreatic insufficiency. We previously reported that in 30% (20/66) of adult celiac patients with current or persistent diarrhea the underlying cause was exocrine pancreatic insufficiency. Of these 20 patients, 19 initially improved on pancreatic supplementation. To date, there are no published longitudinal studies.
The 20 patients who had initially received therapy for exocrine pancreatic insufficiency were prospectively followed-up for 4 years. Gastrointestinal symptoms, dietary adherence, celiac antibody status, and dose of enzyme supplementation were recorded. Fecal elastase-1 (Fel-1) was repeated to reassess exocrine pancreatic function.
In the study, 19/20 patients were reviewed, as one had died (mean age 59.7 years, 7 males). The mean duration of celiac disease was 13.2 years. Eleven out of nineteen were still taking enzyme supplementation at a mean dose of 45,000 units of lipase per day. Only 1/11 reported no symptomatic benefit and 8/19 patients had discontinued supplementation because their diarrhea had improved. In the whole group there was a significant increase in Fel-1 levels over time, with median values of 90 μg/g at 0 months, 212 μg/g at 6 months, and 365 μg/g at follow-up (45–66 months)(p < 0.0001).
Fecal elastase-1 is useful in identifying exocrine pancreatic insufficiency in adult celiac patients with diarrhea. Our longitudinal data suggests that pancreatic enzyme supplementation could be discontinued in a substantial proportion of patients as symptoms improve.
- West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003;52:960–965. CrossRef
- Fasano A, Berti I, Geraduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. AMA Arch Intern Med. 2003;163:286–292. CrossRef
- Green PH, Jabri B. Coeliac disease. Lancet. 2003;362:383–391. CrossRef
- Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128(4 Suppl 1):S74–S78. CrossRef
- Sanders DS, Hurlstone DP, Stokes RO, et al. The changing face of coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J. 2002;78:31–33. CrossRef
- Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology. 1997;112:1830–1838. CrossRef
- O’Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671–680. CrossRef
- Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016–2021. CrossRef
- Dreiling DA. The pancreatic secretion in the malabsorption syndrome and related malnutrition states. J Mt Sinai Hosp NY. 1957;24:243–250.
- Di Magno EP, Go VLW, Summerskill WHJ. Impaired cholecystokinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue. Gastroenterology. 1972;63:25–32.
- Regan PT, DiMagno EP. Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure. Gastroenterology. 1980;78:484–487.
- Weizman Z, Hamilton JR, Kopelman HR, Cleghorn G, Durie PR. Treatment failure in celiac disease due to coexistent exocrine pancreatic insufficiency. Pediatrics. 1987;80:924–926.
- Freeman HJ. Hepatobiliary tract and pancreatic disorders in celiac disease. Can J Gastroenterol. 1997;11:77–81.
- Dominguez-Munoz JE, Hieronymus C, Sauerbruch T, Malfertheiner P. Fecal elastase test: evaluation of a new non-invasive pancreatic function test. Am J Gastroenterol. 1995;90:1834–1837.
- Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspary WF, Lembcke B. Immunoreactive elastase 1: clinical evaluation of a new non-invasive test of pancreatic function. Clin Chem. 1996;42:222–226.
- Löser C, Moullgaard A, Folsch UR. Faecal-elastase 1: a novel, highly sensitive, and tubeless pancreatic function test. Gut. 1996;39:580–586. CrossRef
- Glasbrenner B, Schön A, Klatt S, Beckh K, Adler G. Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol. 1996;8:1117–1120. CrossRef
- Katschinski M, Schirra J, Bross A, Goke B, Arnold R. Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis. Pancreas. 1997;15:191–200. CrossRef
- Lankisch PG, Schmidt I, Konig H, et al. Fecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42:551–554. CrossRef
- Carroccio A, Verghi F, Santini B, et al. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption. A collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology. Dig Dis Sci. 2001;46:1335–1342. CrossRef
- Walkowiak J, Herzig KH, Strzykala K, Przyslawski J, Krawczynski M. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics. 2002;110(1 Pt 1):e7. CrossRef
- Sonwalkar SA, Holbrook IB, Phillips I, Kelly SM. A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function. Aliment Pharmacol Ther. 2003;17:467–471. CrossRef
- Elphick DA, Kapur K. Comparing the urinary pancreolauryl ratio and fecal elastase-1 as indicators of pancreatic insufficiency in clinical practice. Pancreatology. 2005;5:196–200. CrossRef
- Leeds JS, Hopper AD, Hurlstone DP, et al. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther. 2007;25:265–271. CrossRef
- Marsh MN. The natural history of gluten sensitivity: defining, refining and re-defining. Q J Med. 1995;85:9–13.
- Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology. 2005;128:S135–141. CrossRef
- Guidelines for the investigation of chronic diarrhoea. Gut 2003;52 (Suppl V).
- Lankisch PG. Now that fecal elastase is available in the United States, should clinicians start using it? Curr Gastroenterol Rep. 2004;6:126–131. CrossRef
- Carroccio A, Iacono G, Lerro P, et al. Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology. 1997;112(6):1839–1844. CrossRef
- Wahab PJ, Hopman WP, Jansen JB. Basal and fat-stimulated plasma peptide YY levels in coeliac disease. Dig Dis Sci. 2001;46(11):2504–2509. CrossRef
- Nousia-Arvanitakis S, Karagiozogiou-Lamboudes T, Aggouridaki C, Malaka-Lambrellis E, Galli-Tsinopoulou A, Xefteri M. Influence of jejunal morphology changes on exocrine pancreatic function in coeliac disease. J Pediatr Gastroenterol Nutr. 1999;29(1):81–85. CrossRef
- Walkowiak J, Herzig KH. Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest. 2001;31(5):425–430. CrossRef
- Amann ST, Bishop M, Curington C, Toskes PP. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas. 1996;13(3):226–230. CrossRef
- Fischer B, Hoh S, Wehler M, Hahn EG, Schneider HT. Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol. 2001;36(7):771–774. CrossRef
- Carroccio A, Guarino A, Zuin G, et al. Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients. Aliment Pharmacol Ther. 2001;15:1619–1625. CrossRef
- Carroccio A, Fontana M, Spagnuolo MI, et al. Pancreatic dysfunction and its association with fat malabsorption in HIV-infected children. Gut. 1998;43:558–563. CrossRef
- Walkowiak J, Nousia-Arvanitakis S, Agguridaki C, et al. Longitudinal follow-up of exocrine pancreatic insufficiency in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test. J Paed Gastroenterol Nutr. 2003;36:474–478. CrossRef
- Cartmell MT, Kingsnorth AN, O’Reilly DA, Porter C, Makhija R. Faecal elastase 1 measurement in chronic pancreatitis. Clin Chem Lab Med. 2005;43:97–98. CrossRef
- Carroccio A, Iacono G, Montalto G, et al. Pancreatic enzyme therapy in childhood celiac disease. A double-blind prospective randomized study. Dig Dis Sci. 1995;40:2555–2560. CrossRef
- Dickey W, Bodkin S. Prospective study of body mass index in patients with coeliac disease. Br Med J. 1998;317:1290.
- Pancreatic Insufficiency in Adult Celiac Disease: Do Patients Require Long-Term Enzyme Supplementation?
Digestive Diseases and Sciences
Volume 55, Issue 10 , pp 2999-3004
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Celiac disease
- Exocrine pancreatic insufficiency
- Industry Sectors
- Author Affiliations
- 1. Department of Gastroenterology, Sheffield Teaching Hospitals Trust, Sheffield, UK
- 3. Room P39, Department of Gastroenterology and Liver Unit, Royal Hallamshire Hospital, Sheffield, South Yorkshire, S10 2JF, UK
- 2. Department of Clinical Chemistry, Royal Hallamshire Hospital, Sheffield, UK